PolarCool is growing in German elite ice hockey – Eisbären Berlin signs an agreement

19 September 2023 - 10:01

The med-tech company PolarCool AB (publ) continues its successful expansion of PolarCap® System in European ice hockey. The company has signed a 3-year agreement with the German multiple champion team Eisbären Berlin for the use of the PolarCap® System.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussion. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football and handball, but also other sports with an increased risk of concussion.

PolarCool has previously established strategic collaborations in German ice hockey with both Adler Mannheim and Dresdner Eislöwen. The agreement with Eisbären Berlin marks yet another important step for the Company on the international ice hockey market. Eisbären Berlin plays in the German top league DEL and is a nine-time champion.

Eisbären Berlin Sportphysiotherapeut Andre Kreidler comments:

-We are really looking forward to adding the PolarCap® System to our routines for acute concussion management. Our priority is to give our players the best possible conditions to alleviate the effects of concussions.

PolarCool CEO Erik Andersson comments:

-We are very pleased that yet another German ice hockey club chooses to sign an agreement for the use of the PolarCap® System. We notice an increased interest in providing PolarCap® System and foresee that awareness of our treatment method will increase as more clubs sign contracts.

The agreement is in line with PolarCool's overall strategy to introduce the treatment to the international ice hockey market. The agreement is strategically important, even if the financial impact of individual agreements is limited.

For more information

Erik Andersson –  CEO PolarCool AB (publ)               
+46 - 738 60 57 00                                         
E-mail: [email protected]

About PolarCool AB (publ)

PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.

Provided by: Cision
Spotlight Stock Market (Sweden)
PolarCool AB
PolarCool operates in medical technology. The company is focused on offering products and solutions targeted at injuries in sports and physical activity. Main focus is on research and development of products used for the treatment of various brain injuries, for example in boxing, rugby, and American football....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More